Edition:
United States

scPharmaceuticals Inc (SCPH.OQ)

SCPH.OQ on NASDAQ Stock Exchange Global Market

5.53USD
19 Jun 2018
Change (% chg)

$-0.36 (-6.11%)
Prev Close
$5.89
Open
$5.82
Day's High
$5.94
Day's Low
$5.26
Volume
63,143
Avg. Vol
34,218
52-wk High
$18.17
52-wk Low
$5.26

Latest Key Developments (Source: Significant Developments)

Scpharmaceuticals Reports Qtrly Net Loss Per Share Of $0.80
Tuesday, 20 Mar 2018 07:22pm EDT 

March 20 (Reuters) - Scpharmaceuticals Inc ::. REPORTS FOURTH QUARTER 2017 FINANCIAL RESULTS.QTRLY NET LOSS PER SHARE $0.80.  Full Article

Ra Capital Management Reports 16.2 Percent Passive Stake In Scpharmaceuticals
Monday, 11 Dec 2017 05:44pm EST 

Dec 11 (Reuters) - Scpharmaceuticals Inc ::RA CAPITAL MANAGEMENT, LLC REPORTS 16.2 PERCENT PASSIVE STAKE IN SCPHARMACEUTICALS INC AS OF NOVEMBER 17 - SEC FILING.  Full Article

Sun Pharmaceutical Industries Reports 12.3 Percent Stake In Scpharmaceuticals As Of November 21
Monday, 27 Nov 2017 04:12pm EST 

Nov 27 (Reuters) - Scpharmaceuticals Inc ::SUN PHARMACEUTICAL INDUSTRIES LIMITED REPORTS 12.3 PERCENT STAKE IN SCPHARMACEUTICALS INC AS OF NOVEMBER 21 - SEC FILING‍​.SUN PHARMACEUTICAL INDUSTRIES LIMITED SAYS PURCHASED SCPHARMACEUTICALS INC'S COMMON STOCK FOR INVESTMENT PURPOSES.  Full Article

ScPharmaceuticals shares debut about 1.8 pct above IPO price
Friday, 17 Nov 2017 10:26am EST 

Nov 17 (Reuters) - :ScPharmaceuticals Inc shares open at $14.25 in debut on the NASDAQ versus IPO price of $14.00 per share.  Full Article

ScPharmaceuticals Inc prices IPO of 6.4 mln shares at $14/share
Thursday, 16 Nov 2017 09:04pm EST 

Nov 16 (Reuters) - Scpharmaceuticals Inc -:SCPHARMACEUTICALS INC. ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING.SAYS INITIAL PUBLIC OFFERING OF 6.40 MILLION COMMON SHARES PRICED AT $14.00PER SHARE.  Full Article

Scpharmaceuticals sees IPO of 6.4 mln shares to be priced between $14.00 and $16.00 per share‍​
Tuesday, 7 Nov 2017 06:43am EST 

Nov 7 (Reuters) - Scpharmaceuticals Inc ::Scpharmaceuticals Inc sees IPO of 6.4 million shares of common stock to be priced between $14.00 and $16.00 per share - SEC filing‍​.Scpharmaceuticals Inc says intends to use about $35 million - $42 million of IPO proceeds for pre-commercial planning and commercialization of furoscix.Scpharmaceuticals - intends to use about $6 million-$8 million of IPO proceeds for automation necessary to increase manufacturing capacity for sc2wear infusor.  Full Article

BRIEF-scPharmaceuticals Reports Qtrly Loss Per Share Of $0.47

* SCPHARMACEUTICALS INC. REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE